Hemoglobin Southampton complicated by cerebral ischemia, moyamoya, and hydroxyurea‐induced methemoglobinemia
Alexander A. Boucher(University of Minnesota), Charles T. Quinn(Dana-Farber Cancer Institute), J. Michael Taylor(Cincinnati Children's Hospital Medical Center), Sudhakar Vadivelu(Cincinnati Children's Hospital Medical Center), Arun Gurunathan(Seattle Children's Hospital), Kiersten Ricci(Cincinnati Children's Hospital Medical Center)
Cited by 5
Related Papers
Efficacy of systemic sirolimus in the treatment of generalized lymphatic anomaly and Gorham–Stout disease
|Pediatric Blood & Cancer|2019|126
Vascular Anomalies
|Hematology/Oncology Clinics of North America|2019|122
Neoadjuvant and Adjuvant Nivolumab and Lirilumab in Patients with Recurrent, Resectable Squamous Cell Carcinoma of the Head and Neck
|Clinical Cancer Research|2021|104
Nivolumab for Patients With High-Risk Oral Leukoplakia
|JAMA Oncology|2023|56
How we approach the diagnosis and management of complex lymphatic anomalies
|Pediatric Blood & Cancer|2021|52